Skip to content
  • pharma

Bay leaf

Concern score

Not assessed — no hazard data yet.

Bay leaf in plain language

What it does

We don't have a plain-language description for Bay leaf yet.

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

Regulation

No restrictions found. Bay leaf appears in these published regulatory listings.

  • In marketed US drugs
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 2 active drug products and 2 total products.
    • FDA NDC lists this ingredient in 2 active drug products and 2 total products.Source →

Evidence & sources

No graded research studies for Bay leaf yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

1 data source

Where this comes from

  • FDA National Drug Code Directory

    regulatory · updated 2027-12-31

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often FDA National Drug Code directory has listed Bay leaf in a product composition. These are source records, not Greenveil catalog products.

Source records

2

See products using Bay leaf →

Catalog

Found in these products

Their ingredient lists include Bay leaf; each product's own rating depends on its whole formula, so it is shown on the product page, not here.

Co-occurrence

Often appears with

Ingredients that frequently appear alongside Bay leaf in the catalog.